Longmin Chen
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
-
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
- Genetics 6
- Diabetes and associated disorders 5
-
- T-cell and B-cell Immunology 3
- Co-authors
- Cong-Yi Wang (8 shared papers)Jing Zhang (11 shared papers)Fei Xiong (7 shared papers)Qixiong Qin (2 shared papers)Yuan Zou (2 shared papers)Jingyi Li (2 shared papers)Zhijuan Mao (2 shared papers)Zhe Min (2 shared papers)
- Journals
- Molecular Immunology (2 papers)Cell Death and Disease (2 papers)Cell Death and Differentiation (2 papers)European Respiratory Journal (1 paper)Brain Behavior and Immunity (1 paper)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Longmin Chen
22 papers receiving 724 citations
Longmin Chen's Hit Papers
Peers
Comparison fields: 5 of 77
- Pulmonary and Respiratory Medicine 210
- Neurology 33
- Immunology 68
- Neurology 46
- Clinical Biochemistry 13
Countries citing papers authored by Longmin Chen
This map shows the geographic impact of Longmin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longmin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longmin Chen more than expected).
Fields of papers citing papers by Longmin Chen
This network shows the impact of papers produced by Longmin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longmin Chen. The network helps show where Longmin Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Longmin Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program Hit paper breakdown → | 2021 | 188 |
| 2 | 2020 | 124 | |
| 3 | 2021 | 71 | |
| 4 | 2022 | 63 | |
| 5 | 2019 | 52 | |
| 6 | 2021 | 46 | |
| 7 | 2020 | 36 | |
| 8 | 2022 | 33 | |
| 9 | 2019 | 22 | |
| 10 | 2022 | 19 | |
| 11 | 2016 | 18 | |
| 12 | 2021 | 13 | |
| 13 | 2023 | 10 | |
| 14 | 2025 | 8 | |
| 15 | 2024 | 6 | |
| 16 | 2019 | 5 | |
| 17 | 2023 | 5 | |
| 18 | 2013 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2013 | 3 |
About Longmin Chen
Longmin Chen is a scholar working on Genetics, Immunology, Neurology, Pulmonary and Respiratory Medicine and Computer Networks and Communications, having authored 23 papers that have together received 735 indexed citations. Recurring topics across this work include Diabetes and associated disorders (5 papers), T-cell and B-cell Immunology (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Sensor Technology and Measurement Systems (2 papers), Acoustic Wave Phenomena Research (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Nanoparticle-Based Drug Delivery (1 paper) and Genomics and Chromatin Dynamics (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (210 citations), Neurology (33 citations), Immunology (68 citations), Neurology (46 citations) and Clinical Biochemistry (13 citations). Longmin Chen has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Cong-Yi Wang, Jing Zhang, Fei Xiong, Qixiong Qin, Yuan Zou, Jingyi Li, Zhijuan Mao, Zhe Min, Yongjie Xiong and Zheng Xue. Their work appears in journals such as Molecular Immunology, Cell Death and Disease, Cell Death and Differentiation, European Respiratory Journal and Brain Behavior and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.